AKT1 and Parkinson disease: These findings underscore the interconnected roles of NOX, mitochondrial function, α-synuclein, and PI3K/Akt signaling in PD, suggesting that therapeutic strategies targeting multiple pathways may offer enhanced neuroprotection.